Clinical response to donepezil in mild and moderate dementia: relationship to drug plasma concentration and CYP2D6 and APOE genetic polymorphisms
| dc.creator | Luís Felipe José Ravic de Miranda | |
| dc.creator | Karina Braga Gomes Borges | |
| dc.creator | Pedro Augusto Lopes Tito | |
| dc.creator | Josianne Nicácio Silveira | |
| dc.creator | Gerson Antônio Pianetti | |
| dc.creator | Ricardo Martins Duarte Byrro | |
| dc.creator | Patrícia Regina Henrique Peles | |
| dc.creator | Fernando Henrique Pereira | |
| dc.creator | Thiago Rezende dos Santos | |
| dc.creator | Arthur Goncalves Assini | |
| dc.creator | Valéria Valadares Ribeiro | |
| dc.creator | Edgar Nunes de Moares | |
| dc.creator | Paulo Caramelli | |
| dc.date.accessioned | 2022-03-16T18:30:32Z | |
| dc.date.accessioned | 2025-09-08T23:42:43Z | |
| dc.date.available | 2022-03-16T18:30:32Z | |
| dc.date.issued | 2017 | |
| dc.identifier.doi | 10.3233/JAD-160164 | |
| dc.identifier.issn | 1875-8908 | |
| dc.identifier.uri | https://hdl.handle.net/1843/40162 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Journal of Alzheimer's Disease | |
| dc.rights | Acesso Restrito | |
| dc.subject | Doença de Alzheimer | |
| dc.subject | Demência | |
| dc.subject | Apolipoproteínas E | |
| dc.subject | Citocromo P-450 CYP2D6 | |
| dc.subject | Donepezila | |
| dc.subject | Genética | |
| dc.subject.other | Alzheimer’s disease | |
| dc.subject.other | APOE | |
| dc.subject.other | CYP2D6 | |
| dc.subject.other | Donepezil | |
| dc.subject.other | Genetics | |
| dc.subject.other | Naturalistic study | |
| dc.title | Clinical response to donepezil in mild and moderate dementia: relationship to drug plasma concentration and CYP2D6 and APOE genetic polymorphisms | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 549 | |
| local.citation.issue | 2 | |
| local.citation.spage | 539 | |
| local.citation.volume | 55 | |
| local.description.resumo | The clinical response to donepezil in patients with mild and moderate dementia was investigated in relation to the drug plasma concentration and APOE and CYP2D6 polymorphisms. In a prospective naturalistic observational study, 42 patients with Alzheimer’s disease (AD) and AD with cerebrovascular disease who took donepezil (10 mg) for 12 months were evaluated. Their DNA was genotyped, and the donepezil plasma concentrations were measured after 3, 6, and 12 months. Good responders scored ≥–1 on the Mini-Mental State Examination at 12 months in comparison to the baseline score. The study results indicated the good response pattern was influenced by the concentration of donepezil, but not by APOE and CYP2D6 polymorphisms. | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS | |
| local.publisher.department | ICX - DEPARTAMENTO DE ESTATÍSTICA | |
| local.publisher.department | MED - DEPARTAMENTO DE ANATOMIA E IMAGEM | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://content.iospress.com/articles/journal-of-alzheimers-disease/jad160164 |
Arquivos
Licença do pacote
1 - 1 de 1